nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—PRLR—mammary gland—lung cancer	0.053	0.441	CbGeAlD
Fluoxymesterone—Coma hepatic—Docetaxel—lung cancer	0.0219	0.0676	CcSEcCtD
Fluoxymesterone—Oligospermia—Gemcitabine—lung cancer	0.0185	0.057	CcSEcCtD
Fluoxymesterone—Azoospermia—Gemcitabine—lung cancer	0.0144	0.0444	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Gefitinib—lung cancer	0.0137	0.0422	CcSEcCtD
Fluoxymesterone—Azoospermia—Cisplatin—lung cancer	0.0134	0.0414	CcSEcCtD
Fluoxymesterone—Hirsutism—Erlotinib—lung cancer	0.00958	0.0296	CcSEcCtD
Fluoxymesterone—Oligospermia—Methotrexate—lung cancer	0.00944	0.0292	CcSEcCtD
Fluoxymesterone—Oligospermia—Doxorubicin—lung cancer	0.00817	0.0253	CcSEcCtD
Fluoxymesterone—ESR1—mammary gland—lung cancer	0.00806	0.0671	CbGeAlD
Fluoxymesterone—Azoospermia—Methotrexate—lung cancer	0.00734	0.0227	CcSEcCtD
Fluoxymesterone—Azoospermia—Doxorubicin—lung cancer	0.00636	0.0197	CcSEcCtD
Fluoxymesterone—Amcinonide—ANXA1—lung cancer	0.00569	0.241	CrCbGaD
Fluoxymesterone—ESR1—respiratory system—lung cancer	0.00537	0.0447	CbGeAlD
Fluoxymesterone—Menstruation irregular—Docetaxel—lung cancer	0.00496	0.0153	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gefitinib—lung cancer	0.0047	0.0145	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gefitinib—lung cancer	0.00468	0.0145	CcSEcCtD
Fluoxymesterone—AR—epithelium—lung cancer	0.00457	0.0381	CbGeAlD
Fluoxymesterone—AR—bronchus—lung cancer	0.0045	0.0375	CbGeAlD
Fluoxymesterone—ESR1—epithelium—lung cancer	0.00449	0.0374	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—lung cancer	0.00447	0.0372	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Topotecan—lung cancer	0.00422	0.013	CcSEcCtD
Fluoxymesterone—Alopecia—Pemetrexed—lung cancer	0.00416	0.0129	CcSEcCtD
Fluoxymesterone—Alopecia—Gefitinib—lung cancer	0.00413	0.0128	CcSEcCtD
Fluoxymesterone—NR3C1—respiratory system—lung cancer	0.00396	0.033	CbGeAlD
Fluoxymesterone—Haemoglobin—Teniposide—lung cancer	0.00383	0.0118	CcSEcCtD
Fluoxymesterone—Haemorrhage—Teniposide—lung cancer	0.00381	0.0118	CcSEcCtD
Fluoxymesterone—AR—cardiac atrium—lung cancer	0.0038	0.0316	CbGeAlD
Fluoxymesterone—Alopecia—Teniposide—lung cancer	0.00337	0.0104	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Pemetrexed—lung cancer	0.00334	0.0103	CcSEcCtD
Fluoxymesterone—NR3C1—epithelium—lung cancer	0.00331	0.0276	CbGeAlD
Fluoxymesterone—Paraesthesia—Crizotinib—lung cancer	0.00329	0.0102	CcSEcCtD
Fluoxymesterone—NR3C1—bronchus—lung cancer	0.00326	0.0272	CbGeAlD
Fluoxymesterone—Amenorrhoea—Docetaxel—lung cancer	0.00312	0.00965	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Irinotecan—lung cancer	0.00298	0.0092	CcSEcCtD
Fluoxymesterone—NR3C1—trachea—lung cancer	0.00293	0.0244	CbGeAlD
Fluoxymesterone—Haemoglobin—Vinblastine—lung cancer	0.00292	0.00904	CcSEcCtD
Fluoxymesterone—Haemorrhage—Vinblastine—lung cancer	0.00291	0.00899	CcSEcCtD
Fluoxymesterone—AR—lung—lung cancer	0.00291	0.0242	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Gemcitabine—lung cancer	0.0029	0.00896	CcSEcCtD
Fluoxymesterone—ESR1—lung—lung cancer	0.00285	0.0238	CbGeAlD
Fluoxymesterone—Haemoglobin—Topotecan—lung cancer	0.00284	0.00878	CcSEcCtD
Fluoxymesterone—Haemorrhage—Topotecan—lung cancer	0.00283	0.00873	CcSEcCtD
Fluoxymesterone—Haemoglobin—Erlotinib—lung cancer	0.00281	0.00869	CcSEcCtD
Fluoxymesterone—Haemorrhage—Erlotinib—lung cancer	0.0028	0.00864	CcSEcCtD
Fluoxymesterone—NR3C1—cardiac atrium—lung cancer	0.00275	0.0229	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Cisplatin—lung cancer	0.0027	0.00836	CcSEcCtD
Fluoxymesterone—Alopecia—Vinblastine—lung cancer	0.00257	0.00794	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—lung cancer	0.00251	0.00777	CcSEcCtD
Fluoxymesterone—Alopecia—Topotecan—lung cancer	0.0025	0.00772	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—lung cancer	0.00248	0.00765	CcSEcCtD
Fluoxymesterone—Alopecia—Erlotinib—lung cancer	0.00247	0.00764	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Pemetrexed—lung cancer	0.00246	0.00761	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Gefitinib—lung cancer	0.00245	0.00757	CcSEcCtD
Fluoxymesterone—Hydrocortisone—ANXA1—lung cancer	0.0024	0.102	CrCbGaD
Fluoxymesterone—NR3C1—bone marrow—lung cancer	0.00232	0.0193	CbGeAlD
Fluoxymesterone—Nausea—Crizotinib—lung cancer	0.00217	0.00672	CcSEcCtD
Fluoxymesterone—Alopecia—Vinorelbine—lung cancer	0.00214	0.0066	CcSEcCtD
Fluoxymesterone—NR3C1—lung—lung cancer	0.0021	0.0175	CbGeAlD
Fluoxymesterone—Testosterone Propionate—UGT1A1—lung cancer	0.00208	0.0881	CrCbGaD
Fluoxymesterone—Anxiety—Erlotinib—lung cancer	0.00206	0.00638	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Topotecan—lung cancer	0.00201	0.00621	CcSEcCtD
Fluoxymesterone—Haemoglobin—Irinotecan—lung cancer	0.002	0.00619	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Teniposide—lung cancer	0.002	0.00617	CcSEcCtD
Fluoxymesterone—Haemorrhage—Irinotecan—lung cancer	0.00199	0.00616	CcSEcCtD
Fluoxymesterone—AR—lymph node—lung cancer	0.00199	0.0166	CbGeAlD
Fluoxymesterone—Nausea—Pemetrexed—lung cancer	0.00199	0.00614	CcSEcCtD
Fluoxymesterone—Nausea—Gefitinib—lung cancer	0.00197	0.0061	CcSEcCtD
Fluoxymesterone—Haemoglobin—Gemcitabine—lung cancer	0.00195	0.00603	CcSEcCtD
Fluoxymesterone—ESR1—lymph node—lung cancer	0.00195	0.0163	CbGeAlD
Fluoxymesterone—Amenorrhoea—Doxorubicin—lung cancer	0.00195	0.00602	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—lung cancer	0.00195	0.00602	CcSEcCtD
Fluoxymesterone—Haemorrhage—Gemcitabine—lung cancer	0.00194	0.006	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinblastine—lung cancer	0.00186	0.00574	CcSEcCtD
Fluoxymesterone—Paraesthesia—Topotecan—lung cancer	0.0018	0.00557	CcSEcCtD
Fluoxymesterone—Dexamethasone—ANXA1—lung cancer	0.00179	0.0758	CrCbGaD
Fluoxymesterone—Gynaecomastia—Methotrexate—lung cancer	0.00177	0.00547	CcSEcCtD
Fluoxymesterone—Alopecia—Irinotecan—lung cancer	0.00176	0.00544	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Vinorelbine—lung cancer	0.00172	0.00531	CcSEcCtD
Fluoxymesterone—Alopecia—Gemcitabine—lung cancer	0.00172	0.0053	CcSEcCtD
Fluoxymesterone—Headache—Teniposide—lung cancer	0.0017	0.00524	CcSEcCtD
Fluoxymesterone—Haemoglobin—Paclitaxel—lung cancer	0.00163	0.00505	CcSEcCtD
Fluoxymesterone—Haemorrhage—Paclitaxel—lung cancer	0.00163	0.00503	CcSEcCtD
Fluoxymesterone—Nausea—Teniposide—lung cancer	0.00161	0.00497	CcSEcCtD
Fluoxymesterone—Alopecia—Cisplatin—lung cancer	0.0016	0.00494	CcSEcCtD
Fluoxymesterone—Paraesthesia—Vinorelbine—lung cancer	0.00154	0.00477	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinblastine—lung cancer	0.00152	0.00471	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—lung cancer	0.00148	0.00459	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Topotecan—lung cancer	0.00148	0.00457	CcSEcCtD
Fluoxymesterone—Alopecia—Etoposide—lung cancer	0.00147	0.00453	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—lung cancer	0.00144	0.012	CbGeAlD
Fluoxymesterone—Alopecia—Paclitaxel—lung cancer	0.00144	0.00444	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Irinotecan—lung cancer	0.00142	0.00438	CcSEcCtD
Fluoxymesterone—Haemoglobin—Docetaxel—lung cancer	0.00139	0.00428	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Gemcitabine—lung cancer	0.00138	0.00426	CcSEcCtD
Fluoxymesterone—Haemorrhage—Docetaxel—lung cancer	0.00138	0.00426	CcSEcCtD
Fluoxymesterone—Anxiety—Cisplatin—lung cancer	0.00134	0.00413	CcSEcCtD
Fluoxymesterone—Headache—Vinblastine—lung cancer	0.00129	0.004	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Cisplatin—lung cancer	0.00129	0.00397	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—lung cancer	0.00128	0.00397	CcSEcCtD
Fluoxymesterone—Paraesthesia—Irinotecan—lung cancer	0.00127	0.00393	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Vinorelbine—lung cancer	0.00127	0.00391	CcSEcCtD
Fluoxymesterone—Headache—Topotecan—lung cancer	0.00126	0.00389	CcSEcCtD
Fluoxymesterone—Headache—Erlotinib—lung cancer	0.00124	0.00385	CcSEcCtD
Fluoxymesterone—Paraesthesia—Gemcitabine—lung cancer	0.00124	0.00383	CcSEcCtD
Fluoxymesterone—Nausea—Vinblastine—lung cancer	0.00123	0.00379	CcSEcCtD
Fluoxymesterone—Alopecia—Docetaxel—lung cancer	0.00122	0.00376	CcSEcCtD
Fluoxymesterone—Anxiety—Paclitaxel—lung cancer	0.0012	0.00371	CcSEcCtD
Fluoxymesterone—Nausea—Topotecan—lung cancer	0.00119	0.00369	CcSEcCtD
Fluoxymesterone—Nausea—Erlotinib—lung cancer	0.00118	0.00365	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Etoposide—lung cancer	0.00118	0.00364	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Paclitaxel—lung cancer	0.00116	0.00357	CcSEcCtD
Fluoxymesterone—Paraesthesia—Cisplatin—lung cancer	0.00115	0.00357	CcSEcCtD
Fluoxymesterone—Headache—Vinorelbine—lung cancer	0.00108	0.00333	CcSEcCtD
Fluoxymesterone—Paraesthesia—Etoposide—lung cancer	0.00106	0.00327	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Irinotecan—lung cancer	0.00104	0.00323	CcSEcCtD
Fluoxymesterone—Paraesthesia—Paclitaxel—lung cancer	0.00104	0.00321	CcSEcCtD
Fluoxymesterone—Clobetasol propionate—CYP1A1—lung cancer	0.00103	0.0435	CrCbGaD
Fluoxymesterone—Nausea—Vinorelbine—lung cancer	0.00102	0.00315	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methotrexate—lung cancer	0.000998	0.00309	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methotrexate—lung cancer	0.000993	0.00307	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Docetaxel—lung cancer	0.000979	0.00303	CcSEcCtD
Fluoxymesterone—Prednisolone—CYP2A6—lung cancer	0.000962	0.0408	CrCbGaD
Fluoxymesterone—Hypersensitivity—Cisplatin—lung cancer	0.000947	0.00293	CcSEcCtD
Fluoxymesterone—Headache—Irinotecan—lung cancer	0.000887	0.00274	CcSEcCtD
Fluoxymesterone—Paraesthesia—Docetaxel—lung cancer	0.000879	0.00272	CcSEcCtD
Fluoxymesterone—Alopecia—Methotrexate—lung cancer	0.000878	0.00271	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Etoposide—lung cancer	0.000868	0.00268	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—lung cancer	0.000864	0.00267	CcSEcCtD
Fluoxymesterone—Headache—Gemcitabine—lung cancer	0.000864	0.00267	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—lung cancer	0.00086	0.00266	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Paclitaxel—lung cancer	0.000851	0.00263	CcSEcCtD
Fluoxymesterone—Nausea—Irinotecan—lung cancer	0.000841	0.0026	CcSEcCtD
Fluoxymesterone—Nausea—Gemcitabine—lung cancer	0.00082	0.00253	CcSEcCtD
Fluoxymesterone—Nausea—Cisplatin—lung cancer	0.000764	0.00236	CcSEcCtD
Fluoxymesterone—Alopecia—Doxorubicin—lung cancer	0.00076	0.00235	CcSEcCtD
Fluoxymesterone—Headache—Etoposide—lung cancer	0.000738	0.00228	CcSEcCtD
Fluoxymesterone—Headache—Paclitaxel—lung cancer	0.000724	0.00224	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Docetaxel—lung cancer	0.000721	0.00223	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methotrexate—lung cancer	0.000706	0.00218	CcSEcCtD
Fluoxymesterone—Nausea—Etoposide—lung cancer	0.0007	0.00216	CcSEcCtD
Fluoxymesterone—Nausea—Paclitaxel—lung cancer	0.000686	0.00212	CcSEcCtD
Fluoxymesterone—Megestrol acetate—ABCB1—lung cancer	0.000663	0.0281	CrCbGaD
Fluoxymesterone—Hydrocortisone—ABCG2—lung cancer	0.000658	0.0279	CrCbGaD
Fluoxymesterone—Anxiety—Doxorubicin—lung cancer	0.000635	0.00196	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methotrexate—lung cancer	0.000634	0.00196	CcSEcCtD
Fluoxymesterone—Headache—Docetaxel—lung cancer	0.000613	0.0019	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—lung cancer	0.000611	0.00189	CcSEcCtD
Fluoxymesterone—Progesterone—CYP2A6—lung cancer	0.000599	0.0254	CrCbGaD
Fluoxymesterone—Nausea—Docetaxel—lung cancer	0.000582	0.0018	CcSEcCtD
Fluoxymesterone—Paraesthesia—Doxorubicin—lung cancer	0.000549	0.0017	CcSEcCtD
Fluoxymesterone—Dexamethasone—CYP2A6—lung cancer	0.000548	0.0233	CrCbGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—lung cancer	0.00052	0.00161	CcSEcCtD
Fluoxymesterone—Testosterone—ABCG2—lung cancer	0.000507	0.0215	CrCbGaD
Fluoxymesterone—Triamcinolone—PTGS2—lung cancer	0.000504	0.0214	CrCbGaD
Fluoxymesterone—Dexamethasone—ABCG2—lung cancer	0.00049	0.0208	CrCbGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—lung cancer	0.00045	0.00139	CcSEcCtD
Fluoxymesterone—Headache—Methotrexate—lung cancer	0.000442	0.00137	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1A1—lung cancer	0.00042	0.0178	CrCbGaD
Fluoxymesterone—Nausea—Methotrexate—lung cancer	0.000419	0.0013	CcSEcCtD
Fluoxymesterone—Betamethasone—PTGS2—lung cancer	0.000413	0.0175	CrCbGaD
Fluoxymesterone—Spironolactone—ABCB1—lung cancer	0.000412	0.0175	CrCbGaD
Fluoxymesterone—Norethindrone—ALB—lung cancer	0.000401	0.017	CrCbGaD
Fluoxymesterone—Testosterone—CYP1A1—lung cancer	0.000397	0.0168	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP2E1—lung cancer	0.000389	0.0165	CrCbGaD
Fluoxymesterone—Dexamethasone—CYP1A1—lung cancer	0.000384	0.0163	CrCbGaD
Fluoxymesterone—Norethindrone—ABCB1—lung cancer	0.000383	0.0162	CrCbGaD
Fluoxymesterone—Headache—Doxorubicin—lung cancer	0.000383	0.00118	CcSEcCtD
Fluoxymesterone—Methyltestosterone—ALB—lung cancer	0.000381	0.0162	CrCbGaD
Fluoxymesterone—Nausea—Doxorubicin—lung cancer	0.000363	0.00112	CcSEcCtD
Fluoxymesterone—Prednisolone—ABCB1—lung cancer	0.000358	0.0152	CrCbGaD
Fluoxymesterone—Betamethasone—ABCB1—lung cancer	0.000351	0.0149	CrCbGaD
Fluoxymesterone—Hydrocortisone—ABCB1—lung cancer	0.000274	0.0116	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000251	0.00047	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—lung cancer	0.00025	0.00047	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.00025	0.000468	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOA1—lung cancer	0.000249	0.000467	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL2—lung cancer	0.000247	0.000464	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000247	0.000464	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—lung cancer	0.000247	0.000463	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000244	0.000459	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000244	0.000458	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000244	0.000458	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	0.000243	0.000456	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—JUN—lung cancer	0.000241	0.000452	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.00024	0.000451	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—lung cancer	0.00024	0.0102	CrCbGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—lung cancer	0.000239	0.000449	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—JUNB—lung cancer	0.000238	0.000446	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000237	0.000444	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000236	0.000444	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—DICER1—lung cancer	0.000236	0.000443	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000236	0.000443	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000234	0.00044	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000234	0.000439	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.000233	0.000438	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1A—lung cancer	0.000233	0.000438	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—lung cancer	0.000233	0.000437	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—DICER1—lung cancer	0.000233	0.000437	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000231	0.000434	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—lung cancer	0.000227	0.000427	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KIT—lung cancer	0.000227	0.000427	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APC—lung cancer	0.000227	0.000427	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000227	0.000426	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000227	0.000426	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000225	0.000422	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGF—lung cancer	0.000225	0.000422	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000224	0.00042	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—lung cancer	0.000223	0.00947	CrCbGaD
Fluoxymesterone—PRLR—Immune System—EP300—lung cancer	0.000222	0.000417	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—lung cancer	0.000221	0.000415	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—lung cancer	0.000221	0.00938	CrCbGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.00022	0.000413	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000219	0.000412	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000219	0.000411	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—lung cancer	0.000219	0.00041	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000219	0.00041	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—lung cancer	0.000218	0.000409	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—lung cancer	0.000218	0.000409	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000218	0.000408	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—POMC—lung cancer	0.000216	0.000406	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	0.000216	0.000406	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—lung cancer	0.000216	0.000405	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	0.000215	0.000404	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—lung cancer	0.000214	0.000401	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	0.000213	0.0004	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000213	0.0004	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RARB—lung cancer	0.000213	0.000399	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AXL—lung cancer	0.000212	0.000399	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6R—lung cancer	0.000211	0.000396	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—lung cancer	0.000211	0.00895	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—CREBBP—lung cancer	0.000211	0.000396	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000209	0.000393	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	0.000208	0.000391	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—lung cancer	0.000208	0.000391	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000208	0.00039	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—lung cancer	0.000208	0.00039	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NPPA—lung cancer	0.000207	0.000389	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000205	0.000385	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—lung cancer	0.000204	0.00866	CrCbGaD
Fluoxymesterone—ESR1—Gene Expression—SKI—lung cancer	0.000204	0.000383	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.000203	0.000381	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000202	0.000378	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAP2K1—lung cancer	0.000201	0.000378	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SKI—lung cancer	0.000201	0.000377	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000201	0.000377	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CD—lung cancer	0.0002	0.000375	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—lung cancer	0.000199	0.000373	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000198	0.000372	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000196	0.000368	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—lung cancer	0.000195	0.000365	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000194	0.000365	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	0.000193	0.000363	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000192	0.00036	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.00019	0.000357	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—lung cancer	0.000189	0.000355	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	0.000188	0.000353	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	0.000188	0.000353	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—lung cancer	0.000186	0.00035	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000182	0.000342	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	0.000182	0.000342	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	0.000182	0.000341	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.000181	0.00034	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—lung cancer	0.000179	0.000336	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—lung cancer	0.000179	0.000335	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RAF1—lung cancer	0.000178	0.000335	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000178	0.000335	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPB1—lung cancer	0.000178	0.000334	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—lung cancer	0.000177	0.000333	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—lung cancer	0.000176	0.000331	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—lung cancer	0.000174	0.000327	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CB—lung cancer	0.000174	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	0.000173	0.000325	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—lung cancer	0.000173	0.000325	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	0.000169	0.000316	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000168	0.000316	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—lung cancer	0.000168	0.000314	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—lung cancer	0.000167	0.000314	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000166	0.000312	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—COL4A2—lung cancer	0.000165	0.00031	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—lung cancer	0.000164	0.000308	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	0.000164	0.000308	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—lung cancer	0.000164	0.000308	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000164	0.000308	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RARB—lung cancer	0.000164	0.000307	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RARB—lung cancer	0.000161	0.000303	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000161	0.000302	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GIPR—lung cancer	0.000161	0.000302	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—lung cancer	0.00016	0.000301	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—lung cancer	0.00016	0.0003	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NPPA—lung cancer	0.00016	0.000299	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NPPA—lung cancer	0.000157	0.000295	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH3—lung cancer	0.000157	0.000295	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—lung cancer	0.000156	0.000293	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—lung cancer	0.000156	0.000292	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	0.000155	0.000291	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—lung cancer	0.000154	0.000289	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—lung cancer	0.000152	0.000285	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—lung cancer	0.000152	0.000285	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—lung cancer	0.000151	0.000284	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	0.000151	0.000283	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—lung cancer	0.000151	0.000283	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—lung cancer	0.00015	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SDC4—lung cancer	0.00015	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—lung cancer	0.00015	0.000281	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—JUNB—lung cancer	0.000149	0.000279	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	0.000148	0.000277	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DUSP3—lung cancer	0.000147	0.000276	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—lung cancer	0.000145	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RHEB—lung cancer	0.000144	0.000271	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—lung cancer	0.000144	0.000269	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—lung cancer	0.000142	0.000267	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—lung cancer	0.00014	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	0.00014	0.000262	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPB1—lung cancer	0.000137	0.000257	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM8—lung cancer	0.000137	0.000257	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—lung cancer	0.000136	0.000256	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	0.000136	0.000255	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—lung cancer	0.000136	0.000255	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPB1—lung cancer	0.000135	0.000254	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—lung cancer	0.000135	0.000253	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—lung cancer	0.000134	0.000252	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—lung cancer	0.000134	0.000252	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SKI—lung cancer	0.000133	0.000249	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	0.000131	0.000247	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—lung cancer	0.000129	0.000241	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	0.000128	0.000241	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—lung cancer	0.000126	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000126	0.000237	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—lung cancer	0.000126	0.000236	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—lung cancer	0.000125	0.000235	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	0.000124	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	0.000124	0.000233	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—lung cancer	0.000122	0.00023	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH3—lung cancer	0.000121	0.000227	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH3—lung cancer	0.000119	0.000223	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—lung cancer	0.000116	0.000217	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PXN—lung cancer	0.000115	0.000216	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—JUNB—lung cancer	0.000114	0.000215	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—JUNB—lung cancer	0.000113	0.000212	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRP—lung cancer	0.000113	0.000212	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKR1C1—lung cancer	0.000113	0.000212	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—OXTR—lung cancer	0.000113	0.000212	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ERCC2—lung cancer	0.000108	0.000202	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—lung cancer	0.000106	0.000199	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GNG11—lung cancer	0.000106	0.000198	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	0.000105	0.000197	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—lung cancer	0.000103	0.000193	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFC—lung cancer	0.0001	0.000189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—lung cancer	9.82e-05	0.000184	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—lung cancer	9.74e-05	0.000183	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADCY1—lung cancer	9.49e-05	0.000178	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—lung cancer	9.4e-05	0.000176	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP2R1B—lung cancer	9.25e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMARCA4—lung cancer	9.25e-05	0.000174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HSPB1—lung cancer	8.92e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTHLH—lung cancer	8.82e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—lung cancer	8.67e-05	0.000163	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ERCC2—lung cancer	8.31e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ANXA1—lung cancer	8.29e-05	0.000156	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ERCC2—lung cancer	8.19e-05	0.000154	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FLT1—lung cancer	8.03e-05	0.000151	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—lung cancer	7.9e-05	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APP—lung cancer	7.86e-05	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH3—lung cancer	7.86e-05	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF9—lung cancer	7.8e-05	0.000146	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—lung cancer	7.5e-05	0.000141	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUNB—lung cancer	7.44e-05	0.00014	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—lung cancer	7.39e-05	0.000139	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STK11—lung cancer	6.76e-05	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO3—lung cancer	6.52e-05	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AVP—lung cancer	6.11e-05	0.000115	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—lung cancer	6.09e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—lung cancer	5.99e-05	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—lung cancer	5.88e-05	0.00011	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—lung cancer	5.78e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB3—lung cancer	5.29e-05	9.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—lung cancer	5.07e-05	9.51e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR1—lung cancer	4.92e-05	9.23e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HIF1A—lung cancer	4.84e-05	9.09e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—lung cancer	4.82e-05	9.05e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—lung cancer	4.69e-05	8.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA1—lung cancer	4.67e-05	8.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—lung cancer	4.63e-05	8.7e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—lung cancer	4.27e-05	8.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—lung cancer	4.27e-05	8.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—lung cancer	4.27e-05	8.01e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGF—lung cancer	4.22e-05	7.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—POMC—lung cancer	4.06e-05	7.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—lung cancer	4.01e-05	7.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6R—lung cancer	3.96e-05	7.44e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—lung cancer	3.96e-05	7.43e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K1—lung cancer	3.78e-05	7.09e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CD—lung cancer	3.75e-05	7.04e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—lung cancer	3.71e-05	6.97e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—lung cancer	3.66e-05	6.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—lung cancer	3.61e-05	6.78e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—lung cancer	3.56e-05	6.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—lung cancer	3.36e-05	6.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAF1—lung cancer	3.35e-05	6.29e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—lung cancer	3.31e-05	6.22e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—lung cancer	3.27e-05	6.14e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CB—lung cancer	3.27e-05	6.14e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—lung cancer	3.25e-05	6.1e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—lung cancer	3.14e-05	5.9e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—lung cancer	3.01e-05	5.65e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—lung cancer	3e-05	5.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—lung cancer	2.93e-05	5.49e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—lung cancer	2.92e-05	5.48e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—lung cancer	2.84e-05	5.33e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—lung cancer	2.83e-05	5.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—lung cancer	2.83e-05	5.3e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—lung cancer	2.69e-05	5.06e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—lung cancer	2.62e-05	4.92e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—lung cancer	2.55e-05	4.79e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—lung cancer	2.53e-05	4.74e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—lung cancer	2.52e-05	4.73e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—lung cancer	2.5e-05	4.7e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—lung cancer	2.47e-05	4.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—lung cancer	2.41e-05	4.53e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—lung cancer	2.35e-05	4.41e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—lung cancer	2.3e-05	4.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—lung cancer	2.17e-05	4.07e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—lung cancer	1.99e-05	3.74e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—lung cancer	1.93e-05	3.62e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—lung cancer	1.84e-05	3.46e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—lung cancer	1.77e-05	3.31e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—lung cancer	1.63e-05	3.06e-05	CbGpPWpGaD
